Tekmira establishes regulatory framework for emergency use of TKM-Ebola
Tekmira announced the FDA has authorized Tekmira to provide TKM-Ebola for treatment under expanded access protocols to subjects with confirmed or suspected Ebola virus infections. TKM-Ebola is an investigational therapeutic being developed under an FDA approved IND. September 22, 2014